Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis
about
Myasthenia gravisIntravenous immunoglobulin for myasthenia gravisIntravenous immunoglobulin for myasthenia gravisPrecision medicine in myasthenia graves: begin from the data precisionClinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyIVIG treatment for progressive stroke in the primary antiphospholipid antibody syndromePotassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Critical care neurology.Neurologic indications for therapeutic plasma exchange: an update.Neurologic indications for therapeutic plasma exchange: 2011 update.Neurologic indications for therapeutic plasma exchange: 2013 update.Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.An approach to evidence-based therapeutic apheresis.National survey of hemapheresis practice in Hungary 2001-2004.Guidelines for treatment of autoimmune neuromuscular transmission disorders.Recent Advances. Neurology.How to handle myasthenic crisis. Essential steps in patient care.Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.Apheresis registry in France: indications, techniques, and complications. French Registry Study Group.Current and future standards in treatment of myasthenia gravisComparative analysis of therapeutic options used for myasthenia gravis.Juvenile myasthenia gravis: a paediatric perspectiveIn vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor.Progress in the treatment of myasthenia gravisSteroid treatment for myasthenia gravis: steroids have an important role.Intravenous immunoglobulin in neurological disease: a specialist review.Therapeutic plasma exchange in the treatment of myasthenia gravis.Comparison of IVIg and PLEX in patients with myasthenia gravis.Plasma exchange for myasthenia gravis.Autoimmune neuromuscular disorders in childhoodUpdate on myasthenia gravis.The neuromuscular junction disordersTreatment of myasthenia gravis based on its immunopathogenesisPlasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.Mycophenolate mofetil and myasthenia gravis.Therapeutic apheresis in neurology critical care.Prospects for a T-cell receptor vaccination against myasthenia gravis.Clinical uses of intravenous immunoglobulin.
P2860
Q21202960-579D99E9-F0B0-4CBE-AF49-59212E0EE870Q24202443-87EAA46C-4EA8-482D-B0D2-AD8B62E1515AQ24242078-5AFC1B7D-76E3-4EEE-B635-CF7CBB2DA2A7Q26748943-C6C96FC3-7D0D-4E10-AC29-43C8E1FF4D5AQ26765172-86772503-1AAD-44A2-A23A-4CD52D942462Q28210517-6762C0BB-124C-4677-8EAA-2F8EB06D4EFFQ28244864-827A8D26-44D5-4913-9BBF-D5BACACB9924Q30276550-A7512FA4-F70C-452B-8996-0F4F6FE5B9A2Q30307728-B937C349-548D-415F-A0B1-064F56DE5B1DQ30454297-989370CF-9C77-4E4E-80C3-096CF68B4338Q30455391-FE4FBBA1-4E09-43BD-8408-9B590416AA02Q30458271-DDB33681-3423-414E-AEDA-A47620D5C8D7Q31039951-DB01D19A-F9CA-43BB-B5A8-012BB5F42182Q33344697-C5B0DF11-FAF7-4C97-9211-1A378BD74488Q33374298-3F671D6C-491F-40BB-999B-2DB4A5673C11Q33558942-3D144EFB-CDC3-44AA-965C-5804AFC2395FQ33704535-8E846250-42BE-477E-A21A-840FF854C6FEQ33897725-8CEDADE5-82CD-45EE-8C06-9951CF1E013DQ33901517-B2A71B75-6CB9-4418-95CE-1A6531A3F52FQ33979746-8DA974BF-278D-483A-B24D-73BFE8F674C5Q33979762-B2F5C739-7F79-48B2-B9EF-EDDD649EFC8DQ34014734-759BC443-C525-4852-BF23-C0E3FC6FC6BFQ34024635-E2EFC5E3-9D84-4FEF-BB5B-DB73220A4C11Q34029492-8506E9CA-F4DF-48F8-9D37-82CE2EF92732Q34127035-0F2F7CBE-5B1A-40E8-AEB5-EB88BB2F9726Q34409088-225AC389-4308-475D-9DC7-4F1B8992D4F8Q34469016-AD0AA390-0A68-4A14-B824-D45734A13286Q34574581-F7E7FEFA-2D72-4D09-AD15-4B6562F44561Q34975594-B1E7EBC0-DF22-4440-ADDE-9B01762437F1Q35030406-9FB93FFA-8CE7-49F5-A9E3-48E8C92343AEQ35041815-7ED695E8-F388-4435-845E-CFB3982B0710Q35512273-C9C7EA20-D61E-4BF8-B153-52FD4E147438Q35520740-D9DF19B1-0C91-4427-BC70-3C5372223D00Q35576415-2DDE69ED-760F-4CE6-A0DA-98214CFABD34Q35675970-02240058-5BE7-4F11-A2E5-6E089B07F501Q35795404-6C97ECAA-4A01-4CBE-A3FB-3052065C5EF4Q36085869-DA41C1B6-3B85-4960-A263-028C7187F21DQ36215377-0C8F4178-7784-4955-9918-14F915F54C37Q36238694-C07FF686-D28A-4BFC-98BD-EAB82A3C2F91Q36264883-7C87EFC8-196C-4C6B-A62F-3C8BCF40B62F
P2860
Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis
description
im Juni 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 1997
@uk
name
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@en
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@nl
type
label
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@en
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@nl
prefLabel
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@en
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@nl
P2093
P356
P1433
P1476
Clinical trial of plasma excha ...... oglobulin in myasthenia gravis
@en
P2093
Bernard Clair
Claude Chastang
Philippe Gajdos
P304
P356
10.1002/ANA.410410615
P577
1997-06-01T00:00:00Z